BioSpace News Archive

Akoya Biosciences, Inc., The Spatial Biology Company™, announced today that an in-depth comparison of immuno-oncology biomarker types conducted by scientists at Johns Hopkins University, Yale University, and other institutions

SNA International, LLC is proud to announce that we have been named the U.S. Small Business Administration (SBA)'s 2019 Region III Small Business Prime Contractor of the Year.

Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of solid tumors, today announces it has received the approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to proceed with a Phase 1/2a clinical trial of TG6002 administered by intrahepatic artery (IHA) infusion in colorectal cancer patients with unresectable liver metastases (CRLM).

Lysogene (Paris:LYS) (FR0013233475 – LYS), a leading, Phase 3, biopharmaceutical company pioneering gene therapy technologies to treat central nervous system (CNS) diseases, today announced the formation of a Scientific Advisory Board (SAB) comprised of world-leading experts in gene therapy discovery and development

Battelle representatives are participating this week in the TERENO NEON Carbon Workshop 2019 in Düren, Germany, emphasizing the organization’s commitment to environmental research infrastructure (RI), data sharing and interoperability, worldwide research collaboration and building the next generation of researchers.

The Lupus Research Alliance (LRA) affiliate Lupus Therapeutics is pleased to announce that Daniel Wallace, MD is joining its Board of Directors.

Vanguard Surgical, LLC, and Koligo Therapeutics, Inc. announced that Vanguard Surgical has become a KYSLECEL referral center to conduct TP-IAT for eligible patients suffering from chronic or recurrent acute pancreatitis

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Helius Medical Technologies, Inc. (NASDAQ: HSDT) from November 9, 2017 through April 10, 2019, inclusive (the “Class Period”).

Peak Health Center, a 501(c)(3), not-for-profit California corporation, announces the release of Diabet - a 100% natural, plant-based supplement that shows breakthrough potential for supporting healthy blood sugar levels.

The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, has added Innovation and Value Initiative (IVI) to its Strategic Alliance Partnership (SAP) program.